Mitsubishi UFJ Trust & Banking Corp Has $340.67 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Mitsubishi UFJ Trust & Banking Corp reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 2,077,146 shares of the healthcare conglomerate’s stock after selling 12,400 shares during the period. Mitsubishi UFJ Trust & Banking Corp’s holdings in UnitedHealth Group were worth $340,673,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Pittenger & Anderson Inc. boosted its stake in UnitedHealth Group by 5.3% in the fourth quarter. Pittenger & Anderson Inc. now owns 27,760 shares of the healthcare conglomerate’s stock worth $4,443,000 after buying an additional 1,385 shares during the period. IFM Investors Pty Ltd acquired a new stake in UnitedHealth Group during the fourth quarter worth about $1,939,000. Independent Advisor Alliance acquired a new stake in UnitedHealth Group during the fourth quarter worth about $2,318,000. Castleark Management LLC boosted its stake in UnitedHealth Group by 8.4% in the fourth quarter. Castleark Management LLC now owns 325,120 shares of the healthcare conglomerate’s stock worth $52,032,000 after buying an additional 25,090 shares during the period. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main acquired a new stake in UnitedHealth Group during the fourth quarter worth about $58,871,000. Hedge funds and other institutional investors own 86.26% of the company’s stock.

UnitedHealth Group Incorporated (NYSE:UNH) opened at 191.15 on Friday. The company’s 50-day moving average is $186.14 and its 200 day moving average is $172.45. UnitedHealth Group Incorporated has a 1-year low of $132.39 and a 1-year high of $193.00. The firm has a market capitalization of $188.28 billion, a PE ratio of 22.96 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. During the same quarter last year, the firm posted $1.96 EPS. The company’s quarterly revenue was up 7.7% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “[[title]]” was originally posted by [[site]] and is the sole property of of [[site]]. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at [[permalink]].

A number of research firms have issued reports on UNH. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and issued a $205.00 target price (up from $203.00) on shares of UnitedHealth Group in a research note on Friday, July 21st. Sanford C. Bernstein reiterated an “outperform” rating and issued a $210.00 target price (up from $190.00) on shares of UnitedHealth Group in a research note on Saturday, July 22nd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $208.00 target price on shares of UnitedHealth Group in a research note on Friday, July 21st. Royal Bank Of Canada reiterated a “buy” rating and issued a $212.00 target price on shares of UnitedHealth Group in a research note on Thursday, July 20th. Finally, BidaskClub upgraded shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 8th. One investment analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $199.72.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total transaction of $913,200.00. Following the completion of the sale, the director now owns 75,735 shares of the company’s stock, valued at $13,832,240.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the sale, the director now directly owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. Company insiders own 0.89% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).